Cboe Global Markets stock has delivered a 121.3% gain over the past five years, yet recent weakness and a mixed valuation score raise questions about ...
The latest update on Celsius Holdings trims fair value estimates from US$61.35 to US$58.52, signaling a modest reset in what some analysts think the s...
CNBC’s Megan Cassella reports on President Trump's annual financial disclosure report.
Trane Technologies (TT) shows strong breakout potential with a Technical Rating of 8/10 and Setup Quality of 9/10. Positive trends, rising moving aver...
Carnival (CCL) Stock Fair Value Falls After Softer Yield Guidance And Europe Demand Concerns
1 day agoCarnival’s analyst fair value estimate has been revised from US$37.70 to US$35.60, a cut of about 5.6% that resets expectations for where the stock mi...
Wall Street futures edged lower pre-bell Wednesday as traders reviewed Middle East turmoil, rich tec
Strong beer performance lifts quarterly resultsConstellation Brands Inc Class A (NYSE:STZ) reported first-quarter results ahead of Wall Street expecta...
Here's How Much a 1 Percentage Point Difference in Returns Could Cost Your Retirement Over 30 Years
1 day agoThe difference between a robust retirement and one that's cutting it uncomfortably close is largely a matter of limiting the nickel-and-dime costs.
https://investor.gm.com/static-files/2cf99ae7-20dc-49d8-8076-824f96b9d0aa
General Mills topped Wall Street expectations as consumers continued eating at home, while Kroger announced a $1.65 billion acquisition of Giant Eagle...
Constellation Brands (STZ) shares rose early Wednesday after the beer and wine company reported an u
Allegion is set to announce its second-quarter earnings soon, and Wall Street expects the company’s EPS to rise by a single digit.
Raymond James Maintains Outperform on Cass Information Systems, Raises Price Target to $56
1 day agoRaymond James analyst Joseph Yanchunis maintains Cass Information Systems (NASDAQ:CASS) with a Outperform and raises the price target from $52 to $...
This further weakens Amgen’s case for Tavneos’ continued use on the market as the drug comes under intense regulatory scrutiny.
Financial data provider FactSet (NYSE:FDS) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 6.4% year on year to $622.9 million. Th...
Ramp elevates CTO to co-CEO
1 day ago“If you know us, this won’t feel like a change,” wrote Eric Glyman of fellow co-founder Karim Atiyeh’s move to the top of the fintech.
TransMedics: The Margins Must Recover
1 day agoTransMedics is rated Buy as the market overreacts to Q1 margin pressure, while the core growth thesis remains intact. Read more on TMDX stock here.
The Fed's Bank Stress Test Results Are In. Here's What They Mean for Dividends and Buybacks.
1 day agoIt's a good time to invest in bank stocks.
3 Bank Stocks We Keep Off Our Radar
1 day agoBanks use their capital and expertise to help businesses grow while offering consumers essential financial products like mortgages and credit cards. T...
Daiwa Moves PDD Holdings (PDD) to Hold
1 day agoPDD Holdings Inc. (NASDAQ:PDD) is one of the 10 Fastest Growing Asian Stocks to Buy Now. On June 24, 2026, Daiwa downgraded PDD Holdings Inc. (NASDAQ:...
Loading...
